Zaprinast
CAS No. 37762-06-4
Zaprinast ( M&B 22948 )
Catalog No. M14302 CAS No. 37762-06-4
Zaprinast (M&B 22948) is a potent, cGMP-specific phosphodiesterase inhibitor with IC50 of 0.5-0.76 and 0.15 uM for PDE5 and PDE6 respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 50 | In Stock |
|
25MG | 87 | In Stock |
|
50MG | 155 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZaprinast
-
NoteResearch use only, not for human use.
-
Brief DescriptionZaprinast (M&B 22948) is a potent, cGMP-specific phosphodiesterase inhibitor with IC50 of 0.5-0.76 and 0.15 uM for PDE5 and PDE6 respectively.
-
DescriptionZaprinast (M&B 22948) is a potent, cGMP-specific phosphodiesterase inhibitor with IC50 of 0.5-0.76 and 0.15 uM for PDE5 and PDE6 respectively, also is an agonist for GPR35 (EC50=16/840 nM for rat/human GPR35); weakly inhibits PDE9, PDE10, and PDE11 with IC50 of 10-30 uM; enhances the vasodilatory effects of nitric oxide in a range of vascular tissues by prolonging the cGMP-mediated activation of cGMP-dependent protein kinase; also reduces cellular 2HG levels by inhibiting the upstream enzyme glutaminase (GLS), reverses histone hypermethylation and soft-agar growth of IDH1-mutant cells.Asthma Discontinued
-
SynonymsM&B 22948
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number37762-06-4
-
Formula Weight271.30
-
Molecular FormulaC13H13N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(NN=N2)=C2NC(C3=CC=CC=C3OCCC)=N1
-
Chemical Name3,6-dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Elhammali A, et al. Cancer Discov. 2014 Jul;4(7):828-39.
2. Taniguchi Y, et al. FEBS Lett. 2006 Sep 18;580(21):5003-8.
3. Frossard N, et al. Br J Pharmacol. 1981 Aug;73(4):933-8.
4. Griffith TM, et al. Eur J Pharmacol. 1985 Jun 7;112(2):195-202.
2. Taniguchi Y, et al. FEBS Lett. 2006 Sep 18;580(21):5003-8.
3. Frossard N, et al. Br J Pharmacol. 1981 Aug;73(4):933-8.
4. Griffith TM, et al. Eur J Pharmacol. 1985 Jun 7;112(2):195-202.
molnova catalog
related products
-
Cilostamide
Cilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
-
Vardenafil hydrochlo...
Vardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.
-
Cilomilast
A potent and selective PDE4 inhibitor with IC50 of 95/120 nM for LPDE4/HPDE4.